Regulatory T cells and asthma

Asthma is a chronic disease of airway inflammation due to excessive T helper cell type 2 (Th2) response. Present treatment based on inhalation of synthetic glucocorticoids can only control Th2-driven chronic eosinophilic inflammation, but cannot change the immune tolerance of the body to external al...

Full description

Saved in:
Bibliographic Details
Published inJournal of Zhejiang University. B. Science Vol. 19; no. 9; pp. 663 - 673
Main Authors Zhao, Sheng-tao, Wang, Chang-zheng
Format Journal Article
LanguageEnglish
Published Hangzhou Zhejiang University Press 01.09.2018
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1673-1581
1862-1783
1862-1783
DOI10.1631/jzus.B1700346

Cover

More Information
Summary:Asthma is a chronic disease of airway inflammation due to excessive T helper cell type 2 (Th2) response. Present treatment based on inhalation of synthetic glucocorticoids can only control Th2-driven chronic eosinophilic inflammation, but cannot change the immune tolerance of the body to external allergens. Regulatory T cells (Tregs) are the main negative regulatory cells of the immune response. Tregs play a great role in regulating allergic, autoimmune, graft-versus-host responses, and other immune responses. In this review, we will discuss the classification and biological characteristics, the established immunomodulatory mechanisms, and the characteristics of induced differentiation of Tregs. We will also discuss the progress of Tregs in the field of asthma. We believe that further studies on the regulatory mechanisms of Tregs will provide better treatments and control strategies for asthma.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Literature Review-3
ObjectType-Review-3
content type line 23
Corresponding Author
ISSN:1673-1581
1862-1783
1862-1783
DOI:10.1631/jzus.B1700346